SCHEMBL7118552

SCHEMBL7118552

O=[Pt]=O.[H+]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL72223 0.89
Water SCHEMBL10360952 0.80
SCHEMBL8101863 0.55
SCHEMBL35827 0.52
SCHEMBL23042743 0.45
SCHEMBL8064688 0.45
SCHEMBL10773596 0.45
SCHEMBL22165398 0.45
SCHEMBL21544551 0.45
Charcoal, Activated SCHEMBL1535100 0.45

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030130509-A1 PROCESS TO PRODUCE 3-CARBON AMINO ALCOHOL SALTS PHARMACIA & UPJOHN COMPANY 2003-07-10 US disclosed
EP-0892792-A1 PROCESS TO PREPARE OXAZOLIDINONES PHARMACIA &amp; UPJOHN COMPANY (US) 1999-01-27 EP disclosed
WO-1997037980-A1 PROCESS TO PREPARE OXAZOLIDINONES PHARMACIA & UPJOHN COMPANY (US) 1997-10-16 WO disclosed
US-4808607-A ATHEROSCLEROSIS, HYPERLIPOPROTEINEMIA SANDOZ PHARM. CORP. (US) 1989-02-28 US disclosed
US-4668794-A CHOLESTEROL BIOSYNTHESIS INHIBITORS SANDOZ PHARM. CORP. (US) 1987-05-26 US disclosed